Declan schreef op 8 januari 2015 16:59:
J.P. Morgan Healthcare Conference
January 12, 2010
Shire plc
Strategy is delivering
• Focused on the needs of patients and physicians
• velaglucerase alfa available in US and EU pre-approval
• REPLAGAL
• increased demand in the EU
• pre-approval access available for US patients
• Launching new products
• INTUNIV
•
Expanding the business through acquisition, progression
of the R&D pipeline and targeted geographic expansion• Aspiration to grow sales in the mid-teens range year-onyear
on average over the course of 2009 through 2015
Ruud.. Is dat toeval ? of is dat toeval ??